1. 216 EXPRESSION PROFILE OF PHOSPHOLIPASE C ISOENZYMES DURING AZACITIDINE AND LENALIDOMIDE THERAPY IN HIGH-RISK MDS. Issue 1 (April 2015) Authors: Follo, M.Y.; Mongiorgi, S.; Clissa, C.; Stanzani, M.; Parisi, S.; Billi, A.M.; Manzoli, L.; Cocco, L.; Finelli, C. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 98 CLINICAL RESPONSE TO THE ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES. A RANDOMIZED PHASE II MULTICENTER STUDY. Issue 1 (April 2015) Authors: Finelli, C.; Clissa, C.; Follo, M.Y.; Stanzani, M.; Parisi, S.; Avanzini, P.; Bosi, C.; Castagnari, B.; Candoni, A.; Crugnola, M.; Giannini, M.B.; Gobbi, M.; Leonardi, G.; Rigolin, G.M.; Russo, D.; Tosi, P.; Visani, G.; Cocco, L.; Cavo, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna. (April 2017) Authors: Follo, M.Y.; Pellagatti, A.; Armstrong, R.N.; Mongiorgi, S.; Astolfi, A.; Indio, V.; Ratti, S.; Clissa, C.; Barraco, M.; Parisi, S.; Manzoli, L.; Pession, A.; Cocco, L.; Boultwood, J.; Finelli, C. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗